CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients

Giovanni Frisullo, Viviana Nociti, Raffaele Iorio, Domenico Plantone, A. Katia Patanella, Pietro A. Tonali, Anna Paola Batocchi

Research output: Contribution to journalArticlepeer-review


A defect of CD4+ regulatory T cells (Treg) seems to be involved in the pathogenesis of multiple sclerosis (MS). Besides Treg, CD8+ T cells also can suppress the immune response. Forkhead box p3 (Foxp3) is known to program the acquisition of suppressive capacities in CD4+ T cells and recent studies showed that in vitro antigen activation leads to Foxp3 expression in CD8+ T cells, gaining of suppressive activity. By flow cytometry we found a lower percentage of circulating CD8+Foxp3+ T cells in relapsing than in remitting patients with MS and in controls. No significant differences were observed in CD8+Foxp3+ T cell percentage between healthy subjects and patients in remission. Our data suggest that peripheral CD8+Foxp3+ T cells may play a role in the maintenance of tolerance in MS.

Original languageEnglish
Pages (from-to)437-441
Number of pages5
JournalHuman Immunology
Issue number5
Publication statusPublished - May 2010


  • CD8 T cells
  • Foxp3
  • Multiple sclerosis
  • Regulatory T cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients'. Together they form a unique fingerprint.

Cite this